GlassScriptPhysician profile
Daren Karl Brooks
NPI 1750767638
$1,381.87
in general payments reported to CMS, 2019-2025
12 companies · $38.18 in 2025
The $38.18 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $596 · 2022: $174 · 2023: $63.50 · 2024: $31.10 · 2025: $38.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $432.33 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $199.98 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $179.54 | 2019-2023 | Blu-U, Odomzo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $148.63 | 2019-2020 | |
| Janssen Biotech, INC. | $124.26 | 2020-2023 | Simponi, Simponi Aria, Stelara |
| Lilly USA, LLC | $96.31 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $71.10 | 2019-2020 | |
| Genzyme Corporation | $41.78 | 2019-2023 | |
| Pacira Pharmaceuticals Incorporated | $31.10 | 2024 | Exparel |
| Pfizer INC. | $22.50 | 2019 | |
| Biofrontera INC. | $20.72 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daren Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.